Recordkeeping and Reporting Requirements for Drug Products Containing Gamma-Hydroxybutyric Acid (GHB)
other · Rule · Final rule. · Published 2005-01-04 · 70 FR 291
Document
Document number
05-56
Federal Register citation
70 FR 291
Type
Rule
Action
Final rule.
Category
other
Publication date
2005-01-04
Abstract
DEA is amending its regulations to require additional recordkeeping and reporting requirements for drug products containing gamma-hydroxybutyric acid (GHB) for which an application has been approved under the Federal Food, Drug, and Cosmetic Act. DEA makes these changes under section 4 of the "Hillory J. Farias and Samantha Reid Date-Rape Drug Prohibition Act of 2000." These additional requirements are necessary to protect against the diversion of GHB for illicit purposes.